Description
Pharvax Biosciences offers RIPMOST-XT, a hematinic tablet formulation that contains 100mg of Ferrous Ascorbate, 1.5mg of Folic Acid, and 7.5mg of Zinc Sulphate Monohydrate. Its tablet dosage form makes it suitable for inclusion in a pharmaceutical product portfolio. For PCD pharma franchise partners, RIPMOST-XT can be a useful addition to an iron, folic acid, and nutritional product portfolio. Pharma professionals who are looking to expand their PCD pharma franchise product portfolio can consider this formulation as part of their business.
Key Product Highlights:
- Ferrous Ascorbate 100 mg
- Folic Acid 1.5 mg
- Zinc Sulphate Monohydrate 7.5 mg
- Packaging: 10 x 10 Tablets
- Suitable for PCD Pharma Franchise
- Useful addition to an iron and nutritional product portfolio
Disclaimer: For business and product information only. This content is not intended as medical or prescription advice
PCD Pharma Franchise for Ferrous Ascorbate, Folic Acid and Zinc Sulphate Tablets – Pharvax Biosciences
Pharvax Biosciences offers Ferrous Ascorbate, Folic Acid and Zinc Sulphate Tablets for PCD pharma franchise across India, under their brand name, RIPMOST-XT. With 250+ pharma products, this company invites pharma professionals, medical representatives, distributors, and marketers across India to join its PCD Pharma Franchise and Monopoly Distribution network.
So, if you’re searching for Ferrous Ascorbate Tablets, Folic Acid Tablets, Iron and Folic Acid Tablets, nutritional formulations, or PCD Pharma Franchise opportunities in India, RIPMOST-XT can be considered for your product range.
Why Choose RIPMOST-XT Tablet
- 3-in-1 Combination: RIPMOST-XT contains Ferrous Ascorbate, Folic Acid, and Zinc Sulphate in one tablet.
- Portfolio Expansion: Helps PCD pharma franchise partners add another product to their pharmaceutical range.
- Nutritional Formulation: It is suitable for portfolios focused on iron, folic acid, and nutritional products.
- Easy Product Marketing: The tablet dosage form makes it convenient for pharma marketing and distribution.
- B2B Product Option: This tablet can be considered by pharma distributors, marketers, and PCD franchise partners looking to expand their product basket.
